Tetracosactide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01284 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 8 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial adrenal hypoplasia with absent pituitary luteinizing hormone | KG + DL |
| 2 | adrenomyodystrophy | KG + DL |
| 3 | Congenital adrenal insuffiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | KG + DL |
| 4 | 46,XY disorder of sex development | KG + DL |
| 5 | PAGOD syndrome | KG + DL |
| 6 | inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | KG + DL |
| 7 | IMAGe syndrome | KG + DL |
| 8 | adrenal cortex disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.